A New Dawn for Alzheimer’s: Phase I Trial Targets Senescent Cells Safely

Gene variant carried by 1 in 5 people may guard against Alzheimer's and Parkinson's, massive study finds

A Single Gene Variant Protects From Both Alzheimer's And Parkinson's

Phase I Clinical Trial Shows Treatment Designed to Clear Senescent Cells in Alzheimer’s Disease is Safe